China NMPA Product Recall - Fully automated biochemical analyzer

Johnson & Johnson, through its subsidiary Ortho-Clinical Diagnostics, Inc. (USA) and Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., initiated a recall for its Fully Automated Biochemical Analyzer (VITROS 5,1) with software version V2.5 and earlier. The recall, reported to the National Medical Products Administration (NMPA) on May 19, 2010, was prompted by a critical software issue. The main violation identified was a delay in software communication, which could prevent accurate updates of dry slide reading information if additional dry slide cartridges were loaded while the analyzer was operational. This issue, affecting 48 units imported into China and globally, required immediate corrective action to maintain proper clinical medicine, immunoassay, and drug concentration monitoring. There were no reported personal injuries associated with this malfunction. The regulatory framework for this action falls under the NMPA's medical device recall guidelines. As required actions, Johnson & Johnson committed to notifying affected customers and deploying on-site engineers to perform software upgrades on all impacted analyzers, with implementation commencing around April 2010. This ensures the continued safe and accurate operation of the medical devices.